ATE411332T1 - 3'-prodrugs von 2'-deoxy-beta-l-nukleosiden - Google Patents

3'-prodrugs von 2'-deoxy-beta-l-nukleosiden

Info

Publication number
ATE411332T1
ATE411332T1 AT01944522T AT01944522T ATE411332T1 AT E411332 T1 ATE411332 T1 AT E411332T1 AT 01944522 T AT01944522 T AT 01944522T AT 01944522 T AT01944522 T AT 01944522T AT E411332 T1 ATE411332 T1 AT E411332T1
Authority
AT
Austria
Prior art keywords
nucleosides
deoxy
prodrugs
beta
Prior art date
Application number
AT01944522T
Other languages
English (en)
Inventor
Martin Bryant
Gilles Gosselin
Jean-Louis Imbach
Original Assignee
Idenix Cayman Ltd
Centre Nat Rech Scient
Univ Montpellier Ii
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idenix Cayman Ltd, Centre Nat Rech Scient, Univ Montpellier Ii filed Critical Idenix Cayman Ltd
Application granted granted Critical
Publication of ATE411332T1 publication Critical patent/ATE411332T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01944522T 2000-06-15 2001-06-15 3'-prodrugs von 2'-deoxy-beta-l-nukleosiden ATE411332T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21210000P 2000-06-15 2000-06-15

Publications (1)

Publication Number Publication Date
ATE411332T1 true ATE411332T1 (de) 2008-10-15

Family

ID=22789563

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01944522T ATE411332T1 (de) 2000-06-15 2001-06-15 3'-prodrugs von 2'-deoxy-beta-l-nukleosiden

Country Status (28)

Country Link
EP (1) EP1296995B1 (de)
JP (1) JP4639032B2 (de)
KR (2) KR20070048277A (de)
CN (3) CN1295242C (de)
AP (1) AP1771A (de)
AR (1) AR035711A1 (de)
AT (1) ATE411332T1 (de)
AU (2) AU2001266927B2 (de)
BR (1) BR0111732A (de)
CA (1) CA2413163C (de)
CZ (1) CZ2003122A3 (de)
DE (1) DE60136181D1 (de)
EA (1) EA005774B1 (de)
ES (1) ES2317912T3 (de)
IL (3) IL153379A0 (de)
MA (1) MA27126A1 (de)
MX (1) MXPA02012443A (de)
MY (1) MY141594A (de)
NO (1) NO20026001L (de)
NZ (2) NZ523632A (de)
OA (1) OA12384A (de)
PE (1) PE20020216A1 (de)
PL (1) PL360404A1 (de)
PY (1) PY0114386A (de)
UY (1) UY26779A1 (de)
WO (1) WO2001096353A2 (de)
YU (1) YU94802A (de)
ZA (2) ZA200300168B (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2319732T3 (es) 2000-04-13 2009-05-12 Pharmasset, Inc. Derivados de nucleosido 3'- o 2'-hidroximetilo sustituido para el tratamiento de infecciones virales.
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
JP5230052B2 (ja) 2000-05-26 2013-07-10 イデニクス（ケイマン）リミテツド フラビウイルスおよびペスチウイルス治療のための方法および組成物
US6787526B1 (en) 2000-05-26 2004-09-07 Idenix Pharmaceuticals, Inc. Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosides
WO2003026589A2 (en) 2001-09-28 2003-04-03 Idenix (Cayman) Limited Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides
AP2005003213A0 (en) 2002-06-28 2005-03-31 Univ Cagliari 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections.
NZ537662A (en) 2002-06-28 2007-10-26 Idenix Cayman Ltd 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
WO2004003000A2 (en) * 2002-06-28 2004-01-08 Idenix (Cayman) Limited 1’-, 2'- and 3'- modified nucleoside derivatives for treating flaviviridae infections
TW200500375A (en) 2002-06-28 2005-01-01 Idenix Cayman Ltd Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae
US7608600B2 (en) 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
DK1572095T3 (en) * 2002-09-13 2015-09-14 Novartis Ag BETA-L-2'-DEOXYNUCLEOTIDES FOR TREATMENT OF RESISTANT HBV STANDS AND COMBINATION THERAPIES
US7824851B2 (en) 2002-11-15 2010-11-02 Idenix Pharmaceuticals, Inc. 2′-branched nucleosides and Flaviviridae mutation
MXPA05006230A (es) 2002-12-12 2005-09-20 Idenix Cayman Ltd Proceso para la produccion de nucleosidos ramificados-2'.
WO2004084453A2 (en) 2003-03-20 2004-09-30 Microbiologica Quimica E Farmaceutica Ltd. METHODS OF MANUFACTURE OF 2'-DEOXY-β-L-NUCLEOSIDES
US7595390B2 (en) 2003-04-28 2009-09-29 Novartis Ag Industrially scalable nucleoside synthesis
CN100503628C (zh) 2003-05-30 2009-06-24 法莫赛特股份有限公司 修饰的氟化核苷类似物
EP1639121A4 (de) 2003-06-30 2008-04-16 Idenix Cayman Ltd Synthese von beta-l-2-desoxynukleosiden
WO2005107742A1 (en) 2004-05-05 2005-11-17 Yale University Novel antiviral helioxanthin analogs
CN101023094B (zh) 2004-07-21 2011-05-18 法莫赛特股份有限公司 烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
BRPI0515279A (pt) 2004-09-14 2008-07-15 Pharmasset Inc preparação de ribofuranosil pirimidinas e purinas 2'fluoro-2'-alquil- substituìdas ou outras opcionalmente substituìdas e seus derivados
US7524831B2 (en) 2005-03-02 2009-04-28 Schering Corporation Treatments for Flaviviridae virus infection
RU2427372C2 (ru) 2005-06-17 2011-08-27 Новартис Аг Применение санглиферина для лечения вируса гепатита с
GB0609178D0 (en) 2006-05-09 2006-06-21 Univ Cardiff Novel compounds
US7897737B2 (en) 2006-12-05 2011-03-01 Lasergen, Inc. 3′-OH unblocked, nucleotides and nucleosides, base modified with photocleavable, terminating groups and methods for their use in DNA sequencing
US7964580B2 (en) 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
TW200946541A (en) 2008-03-27 2009-11-16 Idenix Pharmaceuticals Inc Solid forms of an anti-HIV phosphoindole compound
EA201100001A3 (ru) 2008-06-11 2013-03-29 Лейзеджен, Инк. Нуклеотиды и нуклеозиды и методы их использования в секвенировании днк
US8551973B2 (en) 2008-12-23 2013-10-08 Gilead Pharmasset Llc Nucleoside analogs
CA2748057C (en) 2008-12-23 2018-07-03 Pharmasset, Inc. Nucleoside phosphoramidates
EP2376515A1 (de) 2008-12-23 2011-10-19 Pharmasset, Inc. Synthese von purinnukleosiden
TWI598358B (zh) 2009-05-20 2017-09-11 基利法瑪席特有限責任公司 核苷磷醯胺
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
CL2011000718A1 (es) 2010-03-31 2012-04-09 Gilead Pharmasset Llc Proceso para la preparacion de compuestos fosforados enantiomericos.
US8680071B2 (en) 2010-04-01 2014-03-25 Idenix Pharmaceuticals, Inc. Compounds and pharmaceutical compositions for the treatment of viral infections
PT3042910T (pt) 2010-11-30 2019-04-16 Gilead Pharmasset Llc 2'-espiro-nucleósidos para utilização na terapia da hepatite c
EP2691409B1 (de) 2011-03-31 2018-02-21 Idenix Pharmaceuticals LLC. Verbindungen und zusammensetzungen zur behandlung von virusinfektionen
JP2014526474A (ja) 2011-09-12 2014-10-06 アイディニックス ファーマシューティカルズ インコーポレイテッド ウイルス感染の治療のための化合物および薬学的組成物
MX342195B (es) 2011-09-13 2016-09-20 Lasergen Inc Nucleótidos de terminación de rápida fotodescomposición 5-metoxi, 3' -oh no bloqueados y métodos para secuenciación de ácido nucleico.
AU2012308295B2 (en) 2011-09-16 2017-10-26 Gilead Sciences, Inc. Methods for treating HCV
US8889159B2 (en) 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
AR090699A1 (es) * 2012-04-18 2014-12-03 Biocryst Pharm Inc Compuestos inhibidores de la actividad de la arn polimerasa viral
MY172166A (en) 2013-01-31 2019-11-15 Gilead Pharmasset Llc Combination formulation of two antiviral compounds
EP3650014B1 (de) 2013-08-27 2021-10-06 Gilead Pharmasset LLC Kombinationsformulierung von zwei antiviralen verbindungen
BR112020020804A2 (pt) 2018-04-12 2021-01-12 Modis Therapeutics Inc. Pró-fármacos de desoxinucleosídeos para tratamento de doenças causadas por agrupamentos de nucleotídeos não balanceados

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4958013A (en) * 1989-06-06 1990-09-18 Northwestern University Cholesteryl modified oligonucleotides
IT1246983B (it) * 1990-11-13 1994-12-12 Consiglio Nazionale Ricerche L-2'-desossiuridine e composizioni farmaceutiche che le contengono.
US5559101A (en) * 1994-10-24 1996-09-24 Genencor International, Inc. L-ribofuranosyl nucleosides
SE9603178L (sv) * 1996-08-30 1997-09-22 Scania Cv Ab Anordning vid ett fordon för monterbar anfästning av en förarplatsmodul
ATE313550T1 (de) * 1998-08-10 2006-01-15 Idenix Cayman Ltd Beta-l-2'-deoxynukleoside für die behandlung von hepatitis b virus

Also Published As

Publication number Publication date
CN1452627A (zh) 2003-10-29
IL153379A0 (en) 2003-07-06
AU6692701A (en) 2001-12-24
CZ2003122A3 (cs) 2003-06-18
PE20020216A1 (es) 2002-04-16
KR20070048277A (ko) 2007-05-08
NO20026001D0 (no) 2002-12-13
ZA200404306B (en) 2005-06-15
WO2001096353A3 (en) 2002-04-18
IL153379A (en) 2007-02-11
EP1296995A2 (de) 2003-04-02
KR20030032967A (ko) 2003-04-26
AP1771A (en) 2007-08-23
MXPA02012443A (es) 2004-09-10
IL178864A0 (en) 2007-03-08
PY0114386A (es) 2004-04-01
NZ535246A (en) 2006-06-30
EA005774B1 (ru) 2005-06-30
CN1900104A (zh) 2007-01-24
PL360404A1 (pl) 2004-09-06
EA200300023A1 (ru) 2003-08-28
CN101012259A (zh) 2007-08-08
CA2413163C (en) 2008-11-18
YU94802A (sh) 2006-03-03
AU2001266927B2 (en) 2006-12-14
JP4639032B2 (ja) 2011-02-23
ES2317912T3 (es) 2009-05-01
WO2001096353A2 (en) 2001-12-20
UY26779A1 (es) 2001-12-28
AP2003002713A0 (en) 2003-03-31
MY141594A (en) 2010-05-14
CA2413163A1 (en) 2001-12-20
NO20026001L (no) 2003-02-12
MA27126A1 (fr) 2005-01-03
AR035711A1 (es) 2004-07-07
BR0111732A (pt) 2003-06-24
DE60136181D1 (de) 2008-11-27
ZA200300168B (en) 2004-07-07
NZ523632A (en) 2005-03-24
JP2004533403A (ja) 2004-11-04
EP1296995B1 (de) 2008-10-15
OA12384A (en) 2006-04-17
CN1295242C (zh) 2007-01-17

Similar Documents

Publication Publication Date Title
ATE411332T1 (de) 3'-prodrugs von 2'-deoxy-beta-l-nukleosiden
NO20031268D0 (no) 4-aminokinazoliner
DE69928195D1 (de) Komplettierung von Untrerdruck-Bohrlöchern
ID30590A (id) Celana sekali pakai jenis-celana pendek
EP1294513A4 (de) Lokalisationsspezifische kovalente biokonjugation von proteinen
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
CY2006003I1 (el) Χρηση δαπτομυκινης
DE60126814D1 (de) Inhalation von stickoxid
ID30187A (id) Dongkrak jenis pantagraf
DE60142051D1 (de) Herstellung von perfluorolefinen
DE60132362D1 (de) Herstellung von ultradünnwandigen cordierit-strukturen
NO20031267D0 (no) 4-aminokinazoliner
ID28032A (id) TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2
DE60007360T2 (de) Amorphe modifikation von torasemid
DE60031450D1 (de) Polymorph v von torasemid
EP1192168A4 (de) Galektin
EP1314428A4 (de) Oct-zubereitungen
EP1366056A4 (de) Zubereitung von deoxynukleoside
ID30381A (id) Penggunaan arilalkanoilpiridazina
DE60207900D1 (de) "Suspend"-Paketübertrager
ITRC20000004V0 (it) Deodorante - souvenir "i calandreddhi"
ITRC20010003A1 (it) "fumanello"
PT9613T (pt) Vysor 3 d
UA4579S (uk) Дозиметр-радіометр гамма-бета-випромінювань
ITSA20000021A0 (it) Eufrasia 2000

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties